Close
Show

Drug Research

This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.

Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2

Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2


Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology...

New Velesco Pharma clinical manufacturing facility begins operations


Pharmaceutical development expert, Velesco Pharma, is initiating operations at its new state-of-the-art cGMP clinical manufacturing...
Eisai's DAYVIGO gets approval in Japan to treat insomnia

Eisai’s DAYVIGO gets approval in Japan to treat insomnia


Eisai Co., Ltd. announced that it has obtained the manufacturing and marketing approval in Japan...

Eisai Commences Joint Research and Development of Cancer Gene Panel Test With Personal Genome...


Eisai Co., Ltd. announced that it has entered into a joint research and development agreement...
Medigene, IRICoR and Universite de Montreal sign collaboration and exclusive licensing option on novel cancer antigens

Medigene, IRICoR and Universite de Montreal sign collaboration and exclusive licensing option on novel...


Medigene AG , a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies,...

Predictive Oncology Acquire Quantitative Medicine and an AI Engine that Facilitates Accelerated Drug Discovery...


Predictive Oncology Inc , a knowledge-driven company focused on applying artificial intelligence to personalized medicine...

FDF China to be held in June to boost Chinese pharmaceutical enterprises to “go...


FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai...
Discover the Latest Information and Seize Market Opportunities in the Annual Event of the CRO & CMO Industry

Discover the Latest Information and Seize Market Opportunities in the Annual Event of the...


As the pharmaceutical market demands in China continue to grow, China’s pharmaceutical policies become gradually...
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics

IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets


IONTAS, a leader in the discovery and optimisation of fully human antibodies, announced it has...
BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development

BioMotiv and Atomwise Sign AI Partnership to Transform Therapeutic Development


BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and...